Drug-induced immunological tolerance.

PubWeight™: 3.68‹?› | Rank: Top 1%

🔗 View Article (PMID 13666859)

Published in Nature on June 13, 1959

Authors

R SCHWARTZ, W DAMESHEK

Articles citing this

Antigen localization and migration in immunity and tolerance. N Engl J Med (1998) 3.71

PHAGOCYTOSIS OF THE ANTIGEN, A CRUCIAL STEP IN THE INDUCTION OF THE PRIMARY RESPONSE. Proc Natl Acad Sci U S A (1965) 3.05

Transplantation milestones. Viewed with one- and two-way paradigms of tolerance. JAMA (1995) 2.20

Studies on cyclophosphamide-induced tolerance to sheep erythrocytes. J Exp Med (1967) 2.19

Nonmyeloablative HLA-haploidentical bone marrow transplantation with high-dose posttransplantation cyclophosphamide: effect of HLA disparity on outcome. Biol Blood Marrow Transplant (2010) 2.17

Transplantation tolerance from a historical perspective. Nat Rev Immunol (2001) 2.04

High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease. Blood (2010) 1.99

QUANTITATIVE STUDIES ON THE BEHAVIOR OF SENSITIZED LYMPHOCYTES IN VITRO. II. INHIBITORY INFLUENCE OF THE IMMUNE SUPPRESSOR, IMURAN, ON THE DESTRUCTIVE REACTION OF SENSITIZED LYMPHOID CELLS AGAINST HOMOLOGOUS TARGET CELLS. J Exp Med (1965) 1.98

ANALYSIS OF MECHANISM OF IMMUNOSUPPRESSIVE DRUGS IN RENAL HOMOTRANSPLANTATION. Ann Surg (1964) 1.81

The saga of liver replacement, with particular reference to the reciprocal influence of liver and kidney transplantation (1955-1967). J Am Coll Surg (2002) 1.81

Post-transplantation cyclophosphamide for tolerance induction in HLA-haploidentical bone marrow transplantation. Semin Oncol (2012) 1.63

The effects of 6-mercaptopurine on homograft reactions. J Clin Invest (1960) 1.61

STUDIES ON THE SUPPRESSION OF IMMUNE RESPONSES BY THE PERIWINKLE ALKALOIDS VINCRISTINE AND VINBLASTINE. J Clin Invest (1964) 1.51

High-dose, post-transplantation cyclophosphamide to promote graft-host tolerance after allogeneic hematopoietic stem cell transplantation. Immunol Res (2010) 1.48

Outcomes of Nonmyeloablative HLA-Haploidentical Blood or Marrow Transplantation With High-Dose Post-Transplantation Cyclophosphamide in Older Adults. J Clin Oncol (2015) 1.25

Serologic factors in human transplantation. Ann Surg (1967) 1.22

The specificity of allergic reactions. VI. Unresponsiveness to simple chemicals. J Exp Med (1963) 1.20

INHIBITION BY 6-MERCAPTOPURINE OF POLYARTHRITIS INDUCED BY FREUND'S ADJUVANT. Ann Rheum Dis (1964) 1.12

THE SPECIFICITY OF ALLERGIC REACTIONS. VII. IMMUNOLOGIC UNRESPONSIVENSSS, DELAYED HYPERSENSITIVITY, AND CIRCULATING ANTIBODY TO PROTEINS AND HAPTEN-PROTEIN CONJUGATES IN ADULT GUINEA PIGS. J Exp Med (1964) 1.10

IMMUNOLOGICAL UNRESPONSIVENESS TO PROTEIN ANTIGENS IN RABBITS EXPOSED TO X-IRRADIATION OR 6-MERCAPTOPURINE TREATMENT. Immunology (1963) 1.09

Chimerism and tolerance in transplantation. Proc Natl Acad Sci U S A (2004) 1.07

Nonmyeloablative, HLA-haploidentical bone marrow transplantation with high dose, post-transplantation cyclophosphamide. Pediatr Rep (2011) 1.07

On the mechanism of immunological tolerance in cyclophosphamide-treated mice. Clin Exp Immunol (1970) 1.00

Immunosuppression in the treatment of inflammatory bowel disease. II. The effects of azathioprine on lymphoid cell populations in a double blind trial in ulcerative colitis. Clin Exp Immunol (1976) 0.96

Renal transplantation: a twenty-five year experience. Ann Surg (1976) 0.95

HLA-haploidentical blood or marrow transplantation with high-dose, post-transplantation cyclophosphamide. Bone Marrow Transplant (2015) 0.94

Steps in immunosuppression for renal transplantation. Kidney Int Suppl (1983) 0.93

Hematopoietic SCT from partially HLA-mismatched (HLA-haploidentical) related donors. Bone Marrow Transplant (2008) 0.92

History of clinical transplantation. World J Surg (2000) 0.91

Historic landmarks in clinical transplantation: conclusions from the consensus conference at the University of California, Los Angeles. World J Surg (2000) 0.90

Haploidentical hematopoietic stem cell transplantation: state of art. Bone Marrow Transplant (2015) 0.89

Tolerogenic therapies in transplantation. Front Immunol (2012) 0.88

Immunosuppressive therapy and tolerance of organ allografts. N Engl J Med (2008) 0.88

Dendritic cell-based approaches for therapeutic immune regulation in solid-organ transplantation. J Transplant (2013) 0.85

Personal reflections in transplantation. Surg Clin North Am (1978) 0.84

Suppression of allergic uveitis by 6-mercaptopurine. J Exp Med (1962) 0.82

France and the early history of organ transplantation. Perspect Biol Med (1993) 0.82

Lymphocyte trapping in dog popliteal lymph nodes: the influence of acute uremia and pharmacologic immunosuppression. Ann Surg (1968) 0.81

Treatment of hematological malignancies with nonmyeloablative, HLA-haploidentical bone marrow transplantation and high dose, post-transplantation cyclophosphamide. Best Pract Res Clin Haematol (2011) 0.81

Failure of chemical antibody suppression to prevent fatal anaphylactic shock. Immunology (1963) 0.79

Landmark perspective: The landmark identical twin case. JAMA (1984) 0.79

Liver transplantation. Gastroenterology (1997) 0.78

The present position and future prospects of organ transplantation. Ann R Coll Surg Engl (1968) 0.78

Immunity and tolerance are related, and governed by antigen migration and localization. Transplant Proc (1999) 0.77

The origin of clinical organ transplantation revisited. JAMA (2009) 0.76

Inhibition of the rejection of renal homografts in dogs by drugs. Ann R Coll Surg Engl (1963) 0.76

A modern Cosmas and Damian: Sir Roy Calne and Thomas Starzl receive the 2012 Lasker~Debakey Clinical Medical Research Award. J Clin Invest (2012) 0.76

The birth of clinical organ transplantation. J Am Coll Surg (2001) 0.76

Historical overview of transplantation. Cold Spring Harb Perspect Med (2013) 0.76

Problems with immunosuppressive agents in renal disease. J Clin Pathol Suppl (R Coll Pathol) (1975) 0.75

Therapeutic workshop on modifying the disease process in rheumatoid arthritis: immunosuppression in perspective. Ann Rheum Dis (1982) 0.75

II. Animal experimentation leading to the development of advanced surgical technics. Am J Public Health Nations Health (1967) 0.75

Transplantation. Ulster Med J (1987) 0.75

Effect of preoperative thoracic duct drainage on canine kidney transplantation. J Invest Surg (1997) 0.75

The co-development of liver and kidney transplantation (1955-1967). Southeast Asian J Trop Med Public Health (2003) 0.75

Lister Oration, 1979. Science and service. Ann R Coll Surg Engl (1980) 0.75

Chimerism after Whole Organ Transplant. Guthrie J Donald Guthrie Found Med Res (1993) 0.75

The present state of liver transplantation and the future prospects for intestinal transplantation. Immunol Invest (1989) 0.75

Effect of thoracic duct drainage on the primary and secondary immune responses in rats. Induction of immunological tolerance. Immunology (1972) 0.75

Organ transplantation--then and now. Hosp Physician (1987) 0.75

Cholera toxin-induced tolerance to allografts in mice. Immunology (1987) 0.75

Evolution of thinking and results in kidney transplantation. Ann R Coll Surg Engl (1974) 0.75

Regulation of immune reactivity and tolerance by antigen migration and localization: with particular reference to allo- and xenotransplantation. Transplant Proc (1999) 0.75

The ascension of clinical organ transplantation. Transplant Proc (1999) 0.75

The haemotoxicity of azathioprine in repeat dose studies in the female CD-1 mouse. Int J Exp Pathol (2008) 0.75

SUPPRESSION OF ANTIBODY SYNTHESIS AND PROLONGATION OF HOMOGRAFT SURVIVAL BY CHLORAMPHENICOL. J Exp Med (1964) 0.75

Immunosuppressive drugs. I. Br Med J (1970) 0.75

The development of clinical renal transplantation. Am J Kidney Dis (1990) 0.75

[Grafts of bone marrow after total irradiation of leukemic mice followed by the administration of an antimitotic product]. Bull World Health Organ (1962) 0.75

Transplantation: the realization of a dream. Semin Nucl Med (1988) 0.75

The French Heritage in Clinical Kidney Transplantation. Transplant Rev (Orlando) (1993) 0.75

Characterization of the impaired antipneumococcal polysacharide antibody production in immunosuppressed pediatric patients following cardiac transplantation. J Clin Immunol (2001) 0.75

Articles by these authors

Some speculations on the myeloproliferative syndromes. Blood (1951) 7.78

The syndrome of impending hepatic coma in patients with cirrhosis of the liver given certain nitrogenous substances. N Engl J Med (1952) 5.90

Effects of electrolyte depletion and acid-base disturbance on muscle cations. Am J Physiol (1951) 5.02

Chloramphenicol--a new warning. JAMA (1960) 2.95

Hypersplenism. Med Clin North Am (1950) 2.71

Systemic lupus erythematosus: a complex auto-immune disorder. Ann Intern Med (1958) 2.63

Effect of 6-mercaptopurine on antibody production. Proc Soc Exp Biol Med (1958) 2.50

Splenectomy in blood dyscrasias. N Engl J Med (1950) 2.46

Interstitial pulmonary fibrosis following busulfan therapy. Am J Med (1961) 2.41

The effect of 6-mercaptopurine on primary and secondary immune responses. J Clin Invest (1959) 2.41

Treatment of certain "autoimmune" diseases with antimetabolites; a preliminary report. Trans Assoc Am Physicians (1960) 2.36

The serum chemistry in uncomplicated kwashiorkor. Br J Nutr (1953) 2.20

Therapeutic effect of pituitary adrenocorticotropic hormone (ACTH) in a case of Henoch-Schönlein vascular (anaphylactoid) purpura. J Am Med Assoc (1950) 2.17

The treatment of autoimmune hemolytic anemia with 6-mercaptopurine and thioguanine. Blood (1962) 2.14

The treatment of acquired hemolytic anemia with adrenocorticotrophic hormone (ACTH). N Engl J Med (1950) 2.13

The auto-immune hemolytic anemia of malignant lymphocytic disease. Blood (1955) 2.02

The morphologic responses of the lymphoid system to homografts. I. First and second set responses in normal rabbits. Blood (1962) 1.99

Physiopathology and course of polycythemia vera as related to therapy. J Am Med Assoc (1950) 1.99

Hypersplenism. Bull N Y Acad Med (1955) 1.93

INHIBITION OF IMMEDIATE AND DELAYED HYPERSENSITIVITY IN THE RABBIT BY 6-MERCAPTOPURINE. J Immunol (1964) 1.85

The plasma ammonia and glutamine content in patients with hepatic coma. J Clin Invest (1954) 1.74

Idiopathic thrombocytopenia; review of eighty-nine cases with particular reference to the differentiation and treatment of acute (self-limited and chronic types). AMA Arch Intern Med (1951) 1.71

Thrombopathic thrombocytopenia; successful transfusion of blood platelets. Blood (1950) 1.70

Studies in experimental autoimmune disorders. I. Clinical and laboratory features of autoimmunization (runt disease) in the mouse. Blood (1961) 1.68

The use of radioactive antiglobulin for the detection of erythrocyte sensitization. Blood (1962) 1.62

The effects of 6-mercaptopurine on homograft reactions. J Clin Invest (1960) 1.61

Blood ammonia and electrolytes in hepatic coma. J Lab Clin Med (1953) 1.60

The significance of hemoglobinemia and associated hemosiderinuria, with particular reference to various types of hemolytic anemia. J Lab Clin Med (1951) 1.59

Collection, preservation and transfusion of platelets; with special reference to the factors affecting the survival rate and the clinical effectiveness of transfused platelets. N Engl J Med (1953) 1.56

Leukemia and auto-immunization- some possible relationships. Blood (1959) 1.53

The use of adrenocorticotropic hormone and cortisone in the treatment of leukemia and leukosarcoma. Blood (1951) 1.51

The renal response to administration of acetazolamide (diamox) during salicylate intoxication. Pediatrics (1959) 1.46

[Success of a blood transfusion with silicone-treated syringe in a case of hemorrhagic thrombocytopathy: importance of silicone for survival of platelets after transfusion]. Sang (1950) 1.45

CANINE SYSTEMIC LUPUS ERYTHEMATOSUS. Blood (1965) 1.45

The anemia of the Di Guglielmo syndrome. Blood (1959) 1.44

The viability of stored human platelets. Blood (1960) 1.39

Emergency splenectomy? Surg Gynecol Obstet (1952) 1.37

Etiology of the severe form of idiopathic hypercalcemia of infancy; a defect in vitamin D metabolism. N Engl J Med (1958) 1.36

Corticotropin and cortisone in idiopathic thrombocytopenic purpura. J Am Med Assoc (1952) 1.36

Tissue electrolyte changes of the whole body, muscle, erythrocyte and plasma of rats on a potassium deficient diet. Am J Physiol (1953) 1.34

THE ROLE OF ANTIGEN DOSAGE IN DRUG-INDUCED IMMUNOLOGIC TOLERANCE. J Immunol (1963) 1.33

Cell heterogeneity within the hepatic lobule: quantitative histochemistry. J Histochem Cytochem (1959) 1.32

Dietary protein in the genesis of hepatic coma. N Engl J Med (1954) 1.32

A syndrome resembling adrenal cortical insufficiency associated with long term busulfan (myleran) therapy. Blood (1961) 1.31

AN IMMUNOLOGIC SURVEY OF FORTY-EIGHT PATIENTS WITH MYASTHENIA GRAVIS. N Engl J Med (1964) 1.29

Idiopathic thrombocytopenic purpura; a challenge. Lancet (1953) 1.27

Thrombocytopenic purpura due to quinidine. I. Clinical studies. Blood (1956) 1.26

Treatment of idiopathic thrombocytopenic purpura (ITP) with prednisone. J Am Med Assoc (1958) 1.25

SIDEROBLASTIC ANAEMIA: IS THIS A MALIGNANCY? Br J Haematol (1965) 1.25

Neoplastic lymphoid reticulum cells in the peripheral blood: a histochemical study. Blood (1961) 1.24

Paroxysmal nocturnal hemoglobinuria; the mechanism of hemolysis and its relation to the coagulation mechanism. Blood (1950) 1.24

Autoimmune thrombocytopenic purpura ("ITP" type) with chronic lymphocytic leukemia. Blood (1962) 1.24

Studies on platelets. II. The effect of transfusion of platelet-rich polycythemic blood on the platelets and hemostatic function in "idiopathic" and "secondary" thrombocytopenic purpura. Blood (1952) 1.22

The body hematocrit/venous hematocrit ratio and the "splenic reservoir". Blood (1961) 1.20

Galactose tolerance in glycogen storage disease. Pediatrics (1957) 1.19

Biopsy of bone marrow with the Vim-Silverman needle. J Am Med Assoc (1958) 1.17

Generalized lipoatrophy, hepatic cirrhosis, disturbed carbohydrate metabolism and accelerated growth (lipoatrophic diabetes). Longitudinal observations and metabolic studies. Am J Med (1960) 1.16

EFFECT OF THYMECTOMY ON THE GOLDEN HAMSTER (MESOCRICETUS AURATUS). I. WASTING DISEASE. Blood (1963) 1.16

Treatment of acquired haemolytic anaemia with compound F acetate. Lancet (1952) 1.15

Autologous bone marrow infusion as an adjunct in therapy of malignant disease. Blood (1959) 1.14

A variety of human hemoglobin with 4 distinct electrophoretic components. Blood (1960) 1.11

"Immunoblasts" and "immunocytes"--an attempt at a functional nomenclature. Blood (1963) 1.11

Use of triethylene melamine in treatment of leukemia and leukosarcoma. J Am Med Assoc (1952) 1.10

Splenectomy for pure red-cell hypoplastic (aregenerative) anemia associated with autoimmune hemolytic disease; report of a case. N Engl J Med (1954) 1.10

Metabolic activity of human blood platelets. I. J Lab Clin Med (1956) 1.10

THERAPY OF ACUTE LEUKEMIA, 1965. Blood (1965) 1.07

Linkage tests of Mediterranean anemia with blood groups, blood types, Rh factors and eye color. Am J Hum Genet (1952) 1.07

Studies on platelets. IX. Observations on the properties and mechanism of action of a potent platelet agglutinin detected in the serum of a patient with idiopathic thrombocytopenic purpura, with a note on the pathogenesis of the disease. Blood (1953) 1.07

Cytochemical in studies of glycogen content of lymphocytes in lymphocytic proliferations. Blood (1958) 1.06

Intravenous glucose tolerance in the normal newborn infant: the effects of a double dose of glucose and insulin. Pediatrics (1963) 1.06

METABOLISM OF ORNITHINE AND OTHER AMINO ACIDS IN THE CEREBRO-OCULO-RENAL SYNDROME. Am J Med (1964) 1.06

'Wasting disease' following thymectomy in the hamster. Nature (1963) 1.05

The Di Guglielmo syndrome. Blood (1958) 1.05

Exacerbation of lupus erythematosus following splenectomy in idiopathic thrombocytopenic purpura and autoimmune hemolytic anemia. Am J Med (1956) 1.05

A DIRECT METHOD FOR CHROMOSOME STUDIES OF HUMAN BONE MARROW. Am J Clin Pathol (1964) 1.05

The erythrocyte-coating substance in autoimmune hemolytic disease: its nature and significance. Blood (1958) 1.04

Trypsin-modified erythrocytes; their use as test cells in acquired hemolytic anemia. Am J Clin Pathol (1951) 1.04

The adrenalin (epinephrin) test as applied to hematologic disorders. Blood (1953) 1.04

Acute vascular (Schönlein-Henoch) purpura-an immunologic disease? N Engl J Med (1955) 1.03

Excretion of delta-aminolevulinic acid in lead intoxication. Acta Haematol (1958) 1.03

Biochemical changes in liver associated with kwashiorkor. J Clin Invest (1957) 1.02

Tuberculosis and myelosclerosis with myeloid metaplasia; report of three cases. JAMA (1961) 1.01

Hepatic carbohydrate metabolism in the genesis of neonatal hypoglycemia. Effects of the administration of epinephrine, glucagon, and galactose. Pediatrics (1962) 1.00

Chronic hypoplastic neutropenia. Am J Med (1952) 0.99

DIRECT INJECTION OF THE THYMUS WITH ANTIGENIC SUBSTANCES. Proc Soc Exp Biol Med (1964) 0.98

EFFECT OF THYMECTOMY ON THE GOLDEN HAMSTER (MESOCRICETUS AURATUS). II. STUDIES OF THE IMMUNE RESPONSE IN THYMECTOMIZED AND SPLENECTOMIZED NON-WASTED ANIMALS. Blood (1964) 0.98

The antidiuretic activity of plasma of patients with hepatic cirrhosis, congestive heart failure, hypertension and other clinical disorders. J Clin Invest (1954) 0.98

Hemotoxic reactions to drugs. Postgrad Med (1954) 0.98

Alkaline phosphatase of mature neutrophils in chronic forms of the myeloproliferative syndrome. Am J Clin Pathol (1958) 0.97

The megakaryocytes in idiopathic thrombocytopenic purpura, a form of hypersplenism. Blood (1946) 0.97

Transfusion reactions to plasma constituent of whole blood; their pathogenesis and treatment by washed red blood cell transfusions. Blood (1950) 0.97